Inflammatory Bowel Diseases in 2024 and Beyond: From Diagnosis to Treatment

Dear Colleagues,

We are delighted to introduce a Special Issue focusing on inflammatory bowel diseases (IBDs) in 2024 and beyond, with a dedicated exploration of diagnosis and treatment.

This compilation of scientific research aims to provide an in-depth overview of the current state of research and therapies for IBDs, offering a clear insight into future perspectives. 

IBDs are chronic intestinal disorders typically categorized as Crohn's disease and ulcerative colitis. Diagnosing and treating such conditions pose significant challenges for healthcare professionals due to the intrinsic complexity of clinical presentations and the causal factors involved.

This Special Issue extensively explores the latest advancements in diagnostic techniques, embracing cutting-edge technologies and innovative methodologies. Authors are invited to delve into the intricate landscape of diagnostic challenges, presenting advanced solutions poised to elevate the precision and swiftness of IBD diagnosis.

Additionally, this issue aims to critically examine current and emerging therapies for IBD, offering insightful analyses of conventional treatments. It will introduce fresh perspectives on personalized therapies and pioneering strategies, including avant-garde approaches like gene therapy and personalized medicine.

Addressing crucial aspects of long-term IBD management, this Special Issue will encompass associated complications and their profound impacts on patients' quality of life. The authors aim to provide a lucid perspective on integrating existing therapies with complementary approaches, enriching the overall care paradigm for individuals facing IBD.

In conclusion, this Special Issue stands as an inclusive platform for disseminating the latest research and breakthroughs in the realm of inflammatory bowel diseases.

This Special Issue aims to include various article types, including original research articles, comprehensive reviews, impactful communications, and more.

Potential topics for submission include the following:

1. Advanced diagnostic techniques in IBD: novel imaging and biomarker approaches;
2. Personalized therapies for IBD: from precision medicine to gene therapy;
3. Innovations in endoscopic diagnosis and treatment of inflammatory bowel diseases;
4. Exploring the interplay of gut microbiota in IBD pathogenesis and therapeutic interventions;
5. Long-term complications of IBD: managing challenges and enhancing the quality of life;
6. Updates on the surgical management of IBD: techniques, indications, and outcomes;
7. Patient-centric approaches in IBD care: improving adherence and quality of life;
8. The role of diet therapy in IBD: efficacy, challenges, and dietary interventions;
9. Combined therapies in IBD and comorbid conditions: an integrated approach;
10. Real-world data on the efficacy and safety of biologic therapies in inflammatory bowel diseases.

We encourage authors to contribute their expertise and insights to create a comprehensive body of knowledge that can significantly advance our understanding and management of IBD. 

Dr. Amalia Di Petrillo
Dr. Sara Onali
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• inflammatory bowel disease
• Crohn’s disease
• ulcerative colitis
• target therapy
• nutrition
• early diagnosis
• inflammatory biomarkers